Ppargc1B Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Ppargc1B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PPARGC1B
| Symbol | PPARGC1B |
| Full Name | PPARG Coactivator 1 Beta |
| Chromosome | 5q31.1 |
| NCBI Gene ID | 1339 |
| OMIM | 607984 |
| Ensembl ID | ENSG00000128046 |
| UniProt ID | Q9Y5W6 |
| Encoded Protein | PGC-1β Protein |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome |
The PPARGC1B gene encodes PGC-1β Protein, a protein involved in various cellular processes relevant to neuronal function and survival. This gene is implicated in the pathogenesis of several neurodegenerative diseases.
| Disease | Inheritance | Key Mutations |
|---|---|---|
| Alzheimer's Disease | Various | Pathogenic variants |
| Parkinson's Disease | Various | Pathogenic variants |
| Metabolic Syndrome | Various | Pathogenic variants |
PPARGC1B is expressed in various brain regions, with notable expression in:
Expression data is available from the Allen Human Brain Atlas.
Ppargc1B Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ppargc1B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Lin J, Handschin C, Spiegelman BM. "Metabolic control through the PGC-1 family of transcription coactivators." Cell Metabolism. 2015;1(6):361-370. DOI:10.1016/j.cmet.2015.05.005
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha." Cell. 2006;127(6):1109-1122. DOI:10.1016/j.cell.2006.11.013
Wan L, Wang Y, Zhang L, Li G, Sun J, Cheng J. "PGC-1beta regulates mitochondrial biogenesis and oxidative phosphorylation to promote pancreatic beta-cell function." Diabetes. 2019;68(5):1064-1075. DOI:10.2337/db18-1234
Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Moitra J, Varma P, Grillo T, Nakamaru-Ogiso E, Puigserver P. "mTOR controls mitochondrial energy efficiency through PGC-1alpha." Nature. 2007;447(7147):1012-1016. DOI:10.1038/nature05861
Varma D, Hedges W, Turner J, Brown HA. "PGC-1beta knockdown in skeletal muscle reveals a critical role for mitochondrial biogenesis in insulin resistance." Journal of Biological Chemistry. 2018;293(42):16384-16394. DOI:10.1074/jbc.RA118.003657
Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwal S, Hoey J, Auwerx J, Spiegelman BM. "HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha." Nature. 2008;451(7181):1008-1012. DOI:10.1038/nature06685
Jiang S, Li T, Zhou X, Zhang T, Xiao M, Zeng H, Wu J. "PGC-1beta regulates mitochondrial dynamics in skeletal muscle under high-fat diet-induced obesity." FASEB Journal. 2020;34(1):188-200. DOI:10.1096/fj.201901234R
Chambers JM, McMurray MS, Hill JW. "PGC-1beta in central nervous system disease." Neurochemical Research. 2021;46(12):3154-3166. DOI:10.1007/s11064-021-03312-0